Download Citation
Article Source:
In vivo efficacy of the AKT inhibitor ARQ 092 in Noonan Syndrome with multiple lentigines-associated hypertrophic cardiomyopathy
Wang J,
Chandrasekhar V,
Abbadessa G,
Yu Y,
Schwartz B,
et al.
(2017)
In vivo efficacy of the AKT inhibitor ARQ 092 in Noonan Syndrome with multiple lentigines-associated hypertrophic cardiomyopathy.
PLOS ONE 12(6): e0178905.
https://doi.org/10.1371/journal.pone.0178905